Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fliser

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Kidney International|August 1, 1994
Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failureD Fliser, M Schröter, M Neubeck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease?E Ritz, D Fliser, H Keller, et al.
Kidney & Blood Pressure Research|July 17, 2004
One for all--a multi-use dialysis system for effective treatment of severe thallium intoxicationJ T Kielstein, S Linnenweber, T Schoepke, et al.
Contributions to Nephrology|January 1, 1993
Proteinuria as a function of hypertension and ageD Fliser, H D Klimm, D Hörner, et al.
Journal of Hypertension|May 1, 1996
Albuminuria in normotensive and hypertensive individuals attending offices of general practitionersD Hörner, D Fliser, H P Klimm, et al.
European Journal of Clinical Investigation|July 21, 2009
Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouseN Shushakova, J K Park, J Menne, et al.
Journal of Hypertension|September 1, 1993
Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditionsD Fliser, U Arnold, B Kohl, et al.
Kidney International. Supplement|November 21, 2007
Erythropoietin and progression of CKDF H Bahlmann, J T Kielstein, H Haller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2001
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?J T Kielstein, J C Frölich, H Haller, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1996
Renal findings in patients with short-term type 2 diabetesC K Keller, K H Bergis, D Fliser, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Kidney International|August 1, 1994
Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failureD Fliser, M Schröter, M Neubeck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease?E Ritz, D Fliser, H Keller, et al.
Kidney & Blood Pressure Research|July 17, 2004
One for all--a multi-use dialysis system for effective treatment of severe thallium intoxicationJ T Kielstein, S Linnenweber, T Schoepke, et al.
Contributions to Nephrology|January 1, 1993
Proteinuria as a function of hypertension and ageD Fliser, H D Klimm, D Hörner, et al.
Journal of Hypertension|May 1, 1996
Albuminuria in normotensive and hypertensive individuals attending offices of general practitionersD Hörner, D Fliser, H P Klimm, et al.
European Journal of Clinical Investigation|July 21, 2009
Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouseN Shushakova, J K Park, J Menne, et al.
Journal of Hypertension|September 1, 1993
Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditionsD Fliser, U Arnold, B Kohl, et al.
Kidney International. Supplement|November 21, 2007
Erythropoietin and progression of CKDF H Bahlmann, J T Kielstein, H Haller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2001
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?J T Kielstein, J C Frölich, H Haller, et al.
Journal of the American Society of Nephrology : JASN|December 1, 1996
Renal findings in patients with short-term type 2 diabetesC K Keller, K H Bergis, D Fliser, et al.
Pageof 10